All News

A woman writes a poem about how she leaned on family, faith and friends when a suspicious spot was discovered during her annual mammogram appointment.

Clinical trials are an invaluable resource to the cancer community, as they continually advance treatment options for patients. An expert explains how they work and what patients should know.

Women with breast cancer may benefit from statin therapy after diagnosis, but more research is needed, one study reported.

A cancer survivor whose mother died from the same disease writes a poem about the emotions she has related to being a 15-year survivor.

A patient details how an oncology nurse made him feel better in more ways than one while undergoing cancer treatment.

A cancer survivor who is now in remission writes a poem dedicated to the oncologist who helped save his life but later died from brain cancer.

An oncology nurse’s experience with her own cancer journey has made her a strong support system on several levels for patients with cancer.

Treating lung cancer is more precise than ever, thanks to biomarker testing, which gives clinicians a better understanding of individual’s tumors.

Cancer survivors share a unique connection. In this post, a survivor writes about meeting a stranger with stage 4 cancer who had an incredible impact on him.

Tecentriq plus chemotherapy did not meet the determined progression-free survival goal, so Genentech – the manufacturer of the immunotherapy agent – decided to pull the indication.

In a special poem dedicated to his aunt who died from breast cancer, Javishkar Reddy writes about their connection and the emotions he felt after losing her.

From the New York City chef who cooks for patients with cancer to a patient with cancer being turned away due to an increase in COVID-19 cases, here’s what’s happening in the cancer landscape this week.

An expert from the University of Pennsylvania explains that better communication is needed between physicians and patients with cancer during clinical trials so that patients are better prepared for life after the clinical trial is over.

A cancer survivor describes the agony of experiencing side effects that never go away and how she lives with them.

Surgery for malignant pleural mesothelioma after radiotherapy may increase overall survival rates, according to a study. However, study authors note that the procedure should only be adopted in centers with substantial surgical experience.

In this episode of the “CURE® Talks Cancer” podcast Mel Mann discusses his participation in the clinical trial for Gleevec and how it changed the trajectory of his life.

Inhibiting a cholesterol receptor could prevent a certain type of kidney cancer from growing, according to recent research.

Aggressive treatment based solely on the age of a patient with colorectal cancer is not warranted, a study found.

Tibsovo — which is the first targeted therapy approved for this patient population — improved survival in patients with a subtype of liver cancer.

A patient with pancreatic cancer discusses how far words of kindness can go to individuals dealing with pain and suffering.

A survivor of myxofibrosarcoma expresses his thoughts about cancer recurrence and treatment options in a poem.

A patient details how a nurse made her experience with blood draws, which can be difficult due to compromised veins, a much more pleasant one.

A retired oncology social worker offers several tips on supporting a friend who has cancer, as well as ways to ask for support as a patient with cancer.

A woman with triple positive breast cancer shares an ode to her scars in hopes that other cancer survivors will find solace and connection in her words.

“I like to think the people of Bodie counted every day and made every day count, as hard as their lives were, reminding me to do the same,” writes a woman with metastatic breast cancer about her visit to Bodie State Historic Park.

The approval of Welireg, according to an expert at Massachusetts General Hospital, is “extremely important” and will “dramatically” change how certain von Hippel-Lindau-associated cancers are treated.

The benefits obtained with antihypertensive medications in colorectal cancer may indicate potential mechanisms that act against tumor cells.

Patients with blood cancers may be less likely to derive immunity from the COVID-19 vaccine, though antibody tests should not be the end-all-be-all in guiding their behavior.

Researchers are evaluating the safety and efficacy of zandelisib, an investigational cancer therapy, for the treatment of patients with marginal zone lymphoma and follicular lymphoma who have received at least two prior therapies.

A recently approved antibody-drug conjugate provides another much-needed treatment choice for patients with locally advanced and metastatic urothelial cancer.